A new experimental platform facilitates assessment of the transcriptional and chromatin landscapes of aging yeast

Abstract

Replicative aging of Saccharomyces cerevisiae is an established model system for eukaryotic cellular aging. A limitation in yeast lifespan studies has been the difficulty of separating old cells from young cells in large quantities. We engineered a new platform, the Miniature-chemostat Aging Device (MAD), that enables purification of aged cells at sufficient quantities for genomic and biochemical characterization of aging yeast populations. Using MAD, we measured DNA accessibility and gene expression changes in aging cells. Our data highlight an intimate connection between aging, growth rate, and stress. Stress-independent genes that change with age are highly enriched for targets of the signal recognition particle (SRP). Combining MAD with an improved ATAC-Seq method, we find that increasing proteasome activity reduces rDNA instability usually observed in aging cells, and contrary to published findings, provide evidence that global nucleosome occupancy does not change significantly with age.

Data availability

We've included all processed data in easily accessible tables.Sequencing data have been deposited in GEO under accession codes GSE118581

The following data sets were generated
    1. Hendrickson DG
    2. Soifer I
    (2018) Genomic analysis of aging yeast
    Publicly available at the NCBI Gene Expression Omnibus (accession no: GSE118581).

Article and author information

Author details

  1. David G Hendrickson

    Calico Life Sciences, LLC, South San Francisco, United States
    Competing interests
    David G Hendrickson, Is affiliated with Calico Life Sciences. There are no other competing interests.
  2. Ilya Soifer

    Calico Life Sciences, LLC, South San Francisco, United States
    Competing interests
    Ilya Soifer, Is affiliated with Calico Life Sciences. There are no other competing interests.
  3. Bernd J Wranik

    Calico Life Sciences, LLC, South San Francisco, United States
    Competing interests
    Bernd J Wranik, Is affiliated with Calico Life Sciences. There are no other competing interests.
  4. Griffin Kim

    Calico Life Sciences, LLC, South San Francisco, United States
    Competing interests
    Griffin Kim, Is affiliated with Calico Life Sciences. There are no other competing interests.
  5. Michael Robles

    Calico Life Sciences, LLC, South San Francisco, United States
    Competing interests
    Michael Robles, Is affiliated with Calico Life Sciences. There are no other competing interests.
  6. Patrick A Gibney

    Calico Life Sciences, LLC, South San Francisco, United States
    Competing interests
    Patrick A Gibney, Is affiliated with Calico Life Sciences. There are no other competing interests.
  7. R Scott McIsaac

    Calico Life Sciences, LLC, South San Francisco, United States
    For correspondence
    rsm@calicolabs.com
    Competing interests
    R Scott McIsaac, Is affiliated with Calico Life Sciences. There are no other competing interests.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5339-6032

Funding

This was work was funded by Calico Life Sciences, LLC

Copyright

© 2018, Hendrickson et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 12,985
    views
  • 1,344
    downloads
  • 56
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. David G Hendrickson
  2. Ilya Soifer
  3. Bernd J Wranik
  4. Griffin Kim
  5. Michael Robles
  6. Patrick A Gibney
  7. R Scott McIsaac
(2018)
A new experimental platform facilitates assessment of the transcriptional and chromatin landscapes of aging yeast
eLife 7:e39911.
https://doi.org/10.7554/eLife.39911

Share this article

https://doi.org/10.7554/eLife.39911

Further reading

    1. Computational and Systems Biology
    Harlan P Stevens, Carly V Winegar ... Stephen R Piccolo
    Research Article

    To help maximize the impact of scientific journal articles, authors must ensure that article figures are accessible to people with color-vision deficiencies (CVDs), which affect up to 8% of males and 0.5% of females. We evaluated images published in biology- and medicine-oriented research articles between 2012 and 2022. Most included at least one color contrast that could be problematic for people with deuteranopia (‘deuteranopes’), the most common form of CVD. However, spatial distances and within-image labels frequently mitigated potential problems. Initially, we reviewed 4964 images from eLife, comparing each against a simulated version that approximated how it might appear to deuteranopes. We identified 636 (12.8%) images that we determined would be difficult for deuteranopes to interpret. Our findings suggest that the frequency of this problem has decreased over time and that articles from cell-oriented disciplines were most often problematic. We used machine learning to automate the identification of problematic images. For a hold-out test set from eLife (n=879), a convolutional neural network classified the images with an area under the precision-recall curve of 0.75. The same network classified images from PubMed Central (n=1191) with an area under the precision-recall curve of 0.39. We created a Web application (https://bioapps.byu.edu/colorblind_image_tester); users can upload images, view simulated versions, and obtain predictions. Our findings shed new light on the frequency and nature of scientific images that may be problematic for deuteranopes and motivate additional efforts to increase accessibility.

    1. Computational and Systems Biology
    Matthew Millard, David W Franklin, Walter Herzog
    Research Article

    The force developed by actively lengthened muscle depends on different structures across different scales of lengthening. For small perturbations, the active response of muscle is well captured by a linear-time-invariant (LTI) system: a stiff spring in parallel with a light damper. The force response of muscle to longer stretches is better represented by a compliant spring that can fix its end when activated. Experimental work has shown that the stiffness and damping (impedance) of muscle in response to small perturbations is of fundamental importance to motor learning and mechanical stability, while the huge forces developed during long active stretches are critical for simulating and predicting injury. Outside of motor learning and injury, muscle is actively lengthened as a part of nearly all terrestrial locomotion. Despite the functional importance of impedance and active lengthening, no single muscle model has all these mechanical properties. In this work, we present the viscoelastic-crossbridge active-titin (VEXAT) model that can replicate the response of muscle to length changes great and small. To evaluate the VEXAT model, we compare its response to biological muscle by simulating experiments that measure the impedance of muscle, and the forces developed during long active stretches. In addition, we have also compared the responses of the VEXAT model to a popular Hill-type muscle model. The VEXAT model more accurately captures the impedance of biological muscle and its responses to long active stretches than a Hill-type model and can still reproduce the force-velocity and force-length relations of muscle. While the comparison between the VEXAT model and biological muscle is favorable, there are some phenomena that can be improved: the low frequency phase response of the model, and a mechanism to support passive force enhancement.